|
| 6-[(4-nitrobenzoyl)amino]hexanoic Acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| 9-Fluorenone-1-carboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| 1-Pyrenecarboxylic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| Chrome Azurol S |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| (2Z,5Z)-5-(4-hydroxy-3,5-dimethoxybenzylidene)-3-phenyl-2-(phenylimino)-1,3-thiazolidin-4-one |
|
Salmonella
Yersinia |
TTSS (SPI-1 encode)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Felise HB, et al. 2008. Cell Host Microbe
|
|
| Imidocarb |
|
Escherichia
Yersinia |
TTSS (Type III secretion system)
TTSS (Type III secretion system) |
Preclinical (in vitro)
Preclinical (in vitro) |
Pan NJ, et al. 2009. Antimicrob Agents Chemother
|
|
| N-(1,3-dimethyl-2-oxo-6-pyrrolidin-1-yl-2,3-dihydro-1H-benzimidazol-5-yl)-N'-(3,4-dimethylphenyl)urea |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother |
|
| 1-{4-[(2-nitrophenyl)sulfonyl]piperazin-1-yl}-2-phenoxyethanone |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Hu X, et al. 2013. Bioorg Med Chem Lett |
|
| 2-[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]-5-chloro-N-(3,4-dichlorophenyl)benzamide |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Kauppi AM, et al. 2003. Chem Biol |
|
| 2-chloro-4-{5-[(E)-2-(4,6-dihydroxy-5-nitropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vitro) |
Eriksson J, et al. 2012. Adv Exp Med Biol |
|
| | | |
